EXPLORE OUR RESOURCES
oNKo-innate
Learning Centre
What will you discover today?
Featured Articles
Topics
All News
-
Firing Up the Cold Tumor: A Major Obstacle in Cancer Therapy
Read more: Firing Up the Cold Tumor: A Major Obstacle in Cancer Therapy -
An Introduction to Cytokine Therapy: Your Questions Answered
Read more: An Introduction to Cytokine Therapy: Your Questions Answered -
–
Amid remdesivir craze Gilead finds time for another oncology pact — looping in all things NK cells
Read more: Amid remdesivir craze Gilead finds time for another oncology pact — looping in all things NK cells -
–
Announcing research collaboration with Gilead and Kite
Read more: Announcing research collaboration with Gilead and Kite -
You Have Got a Fast CAR: Chimeric Antigen Receptor NK Cells in Cancer Therapy
Read more: You Have Got a Fast CAR: Chimeric Antigen Receptor NK Cells in Cancer Therapy -
Impact of Tumor and Immunological Heterogeneity on the Anti-Cancer Immune Response
Read more: Impact of Tumor and Immunological Heterogeneity on the Anti-Cancer Immune Response -
A Gene Signature Predicting Natural Killer Cell Infiltration and Improved Survival in Melanoma Patients
Read more: A Gene Signature Predicting Natural Killer Cell Infiltration and Improved Survival in Melanoma Patients -
Quantifying NK cell growth and survival changes in response to cytokines and regulatory checkpoint blockade helps identify optimal culture and expansion conditions
Read more: Quantifying NK cell growth and survival changes in response to cytokines and regulatory checkpoint blockade helps identify optimal culture and expansion conditions -
–
Congratulations to our CSO for winning the 2019 Jacques Miller Medal
Read more: Congratulations to our CSO for winning the 2019 Jacques Miller Medal -
The Emergence of Natural Killer Cells as a Major Target in Cancer Immunotherapy
Read more: The Emergence of Natural Killer Cells as a Major Target in Cancer Immunotherapy -
Molecular insight into targeting the NK cell immune response to cancer
Read more: Molecular insight into targeting the NK cell immune response to cancer